ArticleDrug design, development and therapy2022

Ruscogenin Attenuates Lipopolysaccharide-Induced Septic Vascular Endothelial Dysfunction by Modulating the miR-146a-5p/NRP2/SSH1 Axis.

Danhong Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.